Utility of Targeted, Amplicon-Based Deep Sequencing To Detect Resistance to First-Line Tuberculosis Drugs in Botswana. [electronic resource]
Producer: 20200806ISSN:- 1098-6596
- Adult
- Antitubercular Agents -- therapeutic use
- Botswana
- Female
- High-Throughput Nucleotide Sequencing -- methods
- Humans
- Isoniazid -- therapeutic use
- Male
- Microbial Sensitivity Tests -- methods
- Middle Aged
- Mycobacterium tuberculosis -- drug effects
- Phenotype
- Sensitivity and Specificity
- Tuberculosis, Multidrug-Resistant -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.